GW Pharmaceuticals appoints new CFO and MD

Scott Giacobello has been appointed as Chief Financial Officer and Adam George as Managing Director

Scott Giacobello

GW Pharmaceuticals, a biopharmaceutical company focused on discovering, developing and commercialising novel therapeutics from its cannabinoid product platform, has announced the appointment of Scott Giacobello as Chief Financial Officer.

Reporting to GW’s Chief Executive Officer Justin Gover, Giacobello will be based at the Company’s US headquarters in Carlsbad, California.

Related to this appointment, Adam George, GW’s Chief Financial Officer since 2012, became Managing Director UK, a newly-created executive role with broad leadership responsibilities for UK operations, also reporting to Justin Gover.

“These important leadership appointments reflect GW’s continuing evolution into a transatlantic commercial-stage biopharmaceutical company,” said Justin Gover, GW’s Chief Executive Officer.

“In anticipation of Epidiolex approval and launch, and with GW now solely listed on Nasdaq, we expect to transition from being a Foreign Private Issuer reporting under IFRS to become a domestic registrant reporting under US GAAP and in US dollars in future years.”

“Scott’s significant financial and accounting expertise will be a major asset to the organisation as we make that shift.”

“In addition, with Adam having served as CFO since 2012, his new Managing Director – UK role leverages the broad knowledge he has of our business and provides continuity of strong senior UK-based leadership, essential elements to our continued success.”

Giacobello brings 25 years of finance and operational experience to GW Pharmaceuticals. In late 2016, he served as Chief Financial Officer for Chase Pharmaceuticals Corporation, a clinical stage biopharmaceutical company focused on the development and commercialisation of improved treatments for neurodegenerative disorders.

From 2008 through 2015, Giacobello held senior level finance positions at Allergan, most recently serving as Vice President of Finance for Global Research and Development. While at Allergan, he also served as Vice President of Corporate Finance and Vice President of Internal Audit and Compliance.

Giacobello’s previous experience includes financial positions at the Black and Decker Corporation and Ernst and Young. He holds a bachelor’s degree in business administration from the University of Notre Dame and is a Certified Public Accountant.

Companies